MyHotelMatch S.A. (MHM.PA)
EUR 0.34
(-9.09%)
EUR 0.34
(-9.09%)
| Breakdown | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 1.05 Million | 40 Thousand | 40.76 Thousand | -798 Thousand | -1.92 Million | -38 Thousand |
| Net Income | -706 Thousand | -11 Thousand | 2.95 Million | -3.69 Million | -3.8 Million | -3.36 Million |
| Depreciation & Amortization | 64 Thousand | 20 Thousand | 20.38 Thousand | 841 Thousand | 355 Thousand | -44 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 1.46 Million | - | - | 2.12 Million | 1.37 Million | 3.18 Million |
| Other non-cash items | 252 Thousand | 11 Thousand | -2.95 Million | -69 Thousand | 149 Thousand | 180 Thousand |
| Investing Cash Flow | 322 Thousand | - | - | -904 Thousand | -195 Thousand | -5000.00 |
| Investments in PPE | -588 Thousand | - | - | -904 Thousand | -195 Thousand | -5000.00 |
| Acquisitions | 424 Thousand | - | - | - | - | - |
| Investment purchases | -910 Thousand | - | - | - | - | - |
| Sales/Maturities of investments | 486 Thousand | - | - | - | - | - |
| Other Investing Activities | 364 Thousand | - | - | - | - | - |
| Financing Cash Flow | 458 Thousand | - | - | 1.67 Million | 2.14 Million | 12 Thousand |
| Debt repayment | -43 Thousand | - | - | -3.71 Million | -1.34 Million | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 500 Thousand | - | - | - | 75 Thousand | 200 Thousand |
| Other Financing Activities | 1000.00 | - | - | 5.38 Million | 3.42 Million | -188 Thousand |
| Accounts receivables | 111 Thousand | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | 1.35 Million | - | - | 2.12 Million | 1.37 Million | 3.18 Million |
| Cash at beginning of period | -664 Thousand | 4172.00 | 24 Thousand | 51 Thousand | 23 Thousand | 54 Thousand |
| Cash at end of period | 1.35 Million | 44.17 Thousand | 4172.00 | 24 Thousand | 51 Thousand | 23 Thousand |
| Capital Expenditure | -588 Thousand | - | - | -904 Thousand | -195 Thousand | -5000.00 |
| Effect of forex changes on cash | -664 Thousand | - | - | 1000.00 | - | - |
| Net cash flow / Change in cash | 2.01 Million | 40 Thousand | -19.82 Thousand | -27 Thousand | 28 Thousand | -31 Thousand |
| Free Cash Flow | 466 Thousand | 40 Thousand | 40.76 Thousand | -1.7 Million | -2.11 Million | -43 Thousand |
| Breakdown | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 FY | 2022 Q3 | 2022 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -360.5 Thousand | -360.5 Thousand | -180.65 Thousand | -706 Thousand | -180.65 Thousand | -172.5 Thousand |
| Depreciation & Amortization | 73 Thousand | 73 Thousand | - | 64 Thousand | - | -266 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -307 Thousand | -307 Thousand | - | 1.46 Million | - | 267 Thousand |
| Other non-cash items | 63.5 Thousand | 63.5 Thousand | 180.65 Thousand | 252 Thousand | 180.65 Thousand | 1000.00 |
| Investing Cash Flow | -39 Thousand | -39 Thousand | - | 322 Thousand | - | -210.5 Thousand |
| Investments in PPE | -49 Thousand | -49 Thousand | - | -588 Thousand | - | -210.5 Thousand |
| Acquisitions | - | - | - | 424 Thousand | - | - |
| Investment purchases | - | - | - | -910 Thousand | - | - |
| Sales/Maturities of investments | - | - | - | 486 Thousand | - | - |
| Other Investing Activities | 10 Thousand | 10 Thousand | - | 546 Thousand | - | - |
| Financing Cash Flow | 279.5 Thousand | 279.5 Thousand | - | 458 Thousand | - | 123 Thousand |
| Debt repayment | - | - | - | -43 Thousand | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | 500 Thousand | - | - |
| Other Financing Activities | 279.5 Thousand | 279.5 Thousand | - | 1000.00 | - | 123 Thousand |
| Accounts receivables | - | - | - | 111 Thousand | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | -307 Thousand | -307 Thousand | - | 1.35 Million | - | 267 Thousand |
| Cash at beginning of period | 15.96 Thousand | - | - | 184 Thousand | 148 Thousand | - |
| Cash at end of period | 800 Thousand | -290.5 Thousand | - | 1.35 Million | 148 Thousand | 148 Thousand |
| Capital Expenditure | -49 Thousand | -49 Thousand | - | -588 Thousand | - | -210.5 Thousand |
| Effect of forex changes on cash | 1.07 Million | - | - | -664 Thousand | - | 406 Thousand |
| Net cash flow / Change in cash | 784.03 Thousand | -290.5 Thousand | - | 1.17 Million | - | 148 Thousand |
| Free Cash Flow | -580 Thousand | -580 Thousand | - | 466 Thousand | - | -381 Thousand |
NBIO
LAB
3419
601579
600903
AAPT